All changes for the tissue liver (60)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA1523
pre B-cell leukemia transcription factor 2
Molecular
liver
Mouse
Pbx2
28.0% Increase Gene Expression Level
DAA1541
proteasome (prosome, macropain) subunit, beta type 10
Molecular
liver
Mouse
Psmb10
6.0% Increase Gene Expression Level
DAA1519
receptor accessory protein 6
Molecular
liver
Mouse
Reep6
5.0% Decrease Gene Expression Level
DAA1528
regulation of nuclear pre-mRNA domain containing 1B
Molecular
liver
Mouse
Rprd1b
10.0% Increase Gene Expression Level
DAA594
Cancer of liver and intrahepatic bile ducts
Pathological
liver
Human
—
SeriesMorbidity
DAA637
Chronic liver disease and cirrhosis
Pathological
liver
Human
—
SeriesMorbidity
DAA588
Viral hepatitis
Pathological
liver
Human
—
SeriesMorbidity
DAA2590
Loss of liver regeneration with age
Physiological
liver
Human
—
—
DAA1060
Blood flow to liver decreases
Physiological
liver
Human
—
—
DAA1061
Variability in clearance of hepatically metabolized drugs
Physiological
liver
Human
—
—
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA1523 | pre B-cell leukemia transcription factor 2 | Molecular | liver | Mouse | Pbx2 | 28.0% Increase Gene Expression Level | |
DAA1541 | proteasome (prosome, macropain) subunit, beta type 10 | Molecular | liver | Mouse | Psmb10 | 6.0% Increase Gene Expression Level | |
DAA1519 | receptor accessory protein 6 | Molecular | liver | Mouse | Reep6 | 5.0% Decrease Gene Expression Level | |
DAA1528 | regulation of nuclear pre-mRNA domain containing 1B | Molecular | liver | Mouse | Rprd1b | 10.0% Increase Gene Expression Level | |
DAA594 | Cancer of liver and intrahepatic bile ducts | Pathological | liver | Human | — | SeriesMorbidity | |
DAA637 | Chronic liver disease and cirrhosis | Pathological | liver | Human | — | SeriesMorbidity | |
DAA588 | Viral hepatitis | Pathological | liver | Human | — | SeriesMorbidity | |
DAA2590 | Loss of liver regeneration with age | Physiological | liver | Human | — | — | |
DAA1060 | Blood flow to liver decreases | Physiological | liver | Human | — | — | |
DAA1061 | Variability in clearance of hepatically metabolized drugs | Physiological | liver | Human | — | — |